Research
Researchers map how Arctic groundwater will respond to thawing permafrost
New Dalhousie research reveals how Arctic permafrost aquifers that store and move groundwater are expected to shift as temperatures and sea levels rise. Read more.
Featured News
Wednesday, February 4, 2026
Sciographies returns next week with a brand-new season of stories that spotlight the people and discoveries shaping science at Dalhousie.
Monday, January 12, 2026
Rates of chronic prescription sedative use among older adults are roughly two to three times the Canadian average in parts of Atlantic Canada. In this Q&A, Dr. David Gardner discusses the phenomenon and outlines findings of a recent clinical trial on strategies to help address it.
Friday, January 9, 2026
Dr. OmiSoore Dryden brings visionary leadership to the School of Nursing and the Faculty of Health as Canada Research Chair in Black Health Studies: Antiracism in Health Education and Practice.
Archives - Research
Monday, July 24, 2023
An effective national school food program can help build the foundations for a healthy population. That’s why Ottawa must limit the influence of the food industry on a national school food program.
Thursday, July 13, 2023
The challenge of getting a tracking device the size of a baseball on some of the world's largest, more elusive creatures isn't stopping a team of Dal researchers as they try to learn more about the movement, diet and lifestyle of several whale species.
Friday, June 30, 2023
Humans are exploiting more than one-third of the world's vertebrates and threatening the existence of more than 5,000 species, according to a global study looking at how human predation impacts biodiversity through consumption, trophy hunting and other activities.
Wednesday, June 28, 2023
Now ranked at 298 globally, Dalhousie maintained twelfth place among Canadian universities and remains the top-ranked university in Atlantic Canada.
Tuesday, June 27, 2023
The federal government’s proposed Agile Licensing drug approval regulations mean Canada will have less information about the risks of new medicines, and higher costs.